» Articles » PMID: 38592161

Complete Blood Count (CBC)-Derived Inflammation Indexes Are Useful in Predicting Metabolic Syndrome in Adults with Severe Obesity

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Apr 9
PMID 38592161
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MetS) is a globally increasing pathological condition. Recent research highlighted the utility of complete blood count-derived (CBC) inflammation indexes to predict MetS in adults with obesity. This study examined CBC-derived inflammation indexes (NHR, LHR, MHR, PHR, SIRI, AISI, and SII) in 231 adults with severe obesity (88 males, 143 females; age: 52.3 [36.4-63.3] years), divided based on the presence (MetS+) or absence (MetS-) of MetS. The relationships between the indexes and the cardiometabolic risk biomarkers HOMA-IR, TG/HDL-C, and non-HDL-C were also evaluated. Individuals with metabolic syndrome (MetS+) had significantly higher values of MHR, LHR, NHR, PHR, and SIRI than those without (MetS-) (MHR and NHR: < 0.0001; LHR: = 0.001; PHR: = 0.011; SIRI: = 0.021). These values were positively correlated with the degree of MetS severity. Logistic regression (MHR and NHR: = 0.000; LHR: = 0.002; PHR: = 0.022; SIRI: = 0.040) and ROC analysis (MHR: AUC = 0.6604; LHR: AUC = 0.6343; NHR: AUC = 0.6741; PHR: AUC = 0.6054; SIRI: AUC = 0.5955) confirmed the predictive potential of CBC-derived inflammation indexes for MetS in individuals with severe obesity. CBC-derived inflammation indexes also correlated with HOMA-IR (MHR, LHR, and NHR: < 0.0001; PHR: < 0.001; SIRI: = 0.000) and TG/HDL-C (MHR, LHR, NHR and PHR: < 0.0001; SIRI: = 0.006). In conclusion, this study validates CBC-derived inflammation indexes for predicting MetS in individuals with severe obesity. The relationships between these indexes and cardiometabolic risk factors can enable clinicians to better grade MetS associated with obesity.

Citing Articles

Association between the systemic immune-inflammation index and metabolic syndrome and its components: results from the multi-ethnic study of atherosclerosis (MESA).

Ramezankhani A, Tohidi M, Hadaegh F Cardiovasc Diabetol. 2025; 24(1):78.

PMID: 39955525 PMC: 11830208. DOI: 10.1186/s12933-025-02629-4.


Evaluating the Role of CBC-Derived Indices in Children with Hashimoto's Thyroiditis.

Munteanu A, Juganaru I, Nicoara D, Mang N, Vasilescu R, Brad G Diagnostics (Basel). 2025; 14(24.

PMID: 39767195 PMC: 11675751. DOI: 10.3390/diagnostics14242834.


The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study.

Hashemi S, Kheirandish M, Rafati S, Ghazalgoo A, Amini-Salehi E, Keivanlou M Lipids Health Dis. 2024; 23(1):393.

PMID: 39604922 PMC: 11603836. DOI: 10.1186/s12944-024-02378-5.


A cross-sectional study of factors associated with carotid atherosclerosis.

Dai G, Cai X, Ye C, Zhang Y, Guan R Front Physiol. 2024; 15:1434173.

PMID: 39493866 PMC: 11527631. DOI: 10.3389/fphys.2024.1434173.


Systemic immune inflammation index (SII) assessment as a potential tool against childhood hypertension.

Musial K Pediatr Res. 2024; .

PMID: 39394423 DOI: 10.1038/s41390-024-03633-2.


References
1.
Rohatgi A . High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity. Prog Cardiovasc Dis. 2015; 58(1):32-40. PMC: 4486636. DOI: 10.1016/j.pcad.2015.05.004. View

2.
Brede S, Serfling G, Klement J, Schmid S, Lehnert H . Clinical Scenario of the Metabolic Syndrome. Visc Med. 2016; 32(5):336-341. PMC: 5123021. DOI: 10.1159/000449028. View

3.
Raja V, Aguiar C, Alsayed N, Chibber Y, Elbadawi H, Ezhov M . Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 2023; 383:117312. DOI: 10.1016/j.atherosclerosis.2023.117312. View

4.
Jialal I, Jialal G, Adams-Huet B, Ramakrishnan N . Neutrophil and monocyte ratios to high-density lipoprotein-cholesterol and adiponectin as biomarkers of nascent metabolic syndrome. Horm Mol Biol Clin Investig. 2020; 41(2). DOI: 10.1515/hmbci-2019-0070. View

5.
Lin K, Fan F, Cai M, Yu Y, Fu C, Ding L . Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022; 27(1):106. PMC: 9250264. DOI: 10.1186/s40001-022-00733-9. View